Precision Explorer

Precision Explorer™ is a GenAI-powered application developed by ConcertAI, purpose-built for HEOR, medical affairs, and epidemiology teams working in oncology. It removes the friction associated with legacy analytics processes by enabling dynamic cohort creation, instant outcomes analysis, and citation-backed insights — all without requiring any programming skills. Users can get answers in minutes rather than weeks, empowering faster hypothesis validation and continuous evidence generation.

The platform is designed to serve two primary user groups: Epidemiologists and Medical Affairs professionals who need to generate robust observational evidence, analyze patient populations, and share results internally, in peer-reviewed publications, or in regulatory submissions; and Health Economics and Outcomes Researchers (HEOR) who require evidence on economic value, treatment impacts, and outcomes data to justify pricing and reimbursement decisions with payers, policy makers, and regulators.

Key Value and Impact

• Faster time to insights: Delivers more than 50% reduction in analysis timelines, drastically cutting time spent on data access and cleaning, exploratory and descriptive analysis, statistical modeling, interpretation, and visualizations.
• High explainability: Automatically generates narrative text explanations alongside visuals and data tables, enabling rapid sharing of findings and saving significant rote analysis time.
• Transparency and citation: Provides relevant source citations to increase transparency, drawing from published literature, standard of care guidelines, and national comparisons.
• Shorter time to decision-making: Reduces end-to-end analysis time, increasing research capacity and allowing key decision makers to make informed decisions more rapidly.

Core Capabilities

• Cohort Build and Explore Agent: Enables exploration of real-world data using a natural language, question-and-answer interface with no code required. Capable of contextualizing complex clinical concepts such as event dates related to metastasis, comorbidities, and adverse events, even when references are ambiguous or implicit.
• Real World Outcomes Agent: Supports overall survival (OS) analysis and other real-world outcomes assessments drawn from oncology patient data.
• Comorbidity Analysis Agent: Facilitates population-level comorbidities analysis to understand the broader health burden of patient cohorts.
• Guideline Concordance Assessment Agent: Compares standard of care guidelines against real-world treatment progression, helping teams identify gaps between recommended and actual clinical practice.

Who Benefits from Precision Explorer

• Epidemiologists and Medical Affairs teams use the platform to generate evidence through robust observational study design, appropriate patient sampling, bias and confounding control, and results dissemination that drives business direction and investment decisions.
• HEOR professionals leverage the tool to generate evidence on economic value, patient outcomes, and treatment impacts — information that is crucial to managing the economics of pharmaceutical development, commercialization, and reimbursement negotiations.

Precision Explorer is part of ConcertAI's broader Precision Suite of oncology-focused solutions. It is designed to help research teams identify patients, compare treatments, and analyze outcomes with greater speed and clarity, supporting both internal decision-making and external submissions to regulators and payers.